Hologic Inc.

NASDAQ: HOLX · Real-Time Price · USD
54.13
-3.15 (-5.50%)
At close: May 02, 2025, 3:59 PM
53.50
-1.17%
After-hours: May 02, 2025, 07:45 PM EDT
-5.50%
Bid 52.5
Market Cap 12.15B
Revenue (ttm) 4.03B
Net Income (ttm) 556.7M
EPS (ttm) 3.16
PE Ratio (ttm) 17.13
Forward PE 12.34
Analyst Hold
Ask 56.4
Volume 6,835,065
Avg. Volume (20D) 2,820,319
Open 54.74
Previous Close 57.28
Day's Range 52.12 - 55.53
52-Week Range 52.12 - 84.67
Beta 0.83

About HOLX

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima vi...

Sector Healthcare
IPO Date Mar 1, 1990
Employees 7,063
Stock Exchange NASDAQ
Ticker Symbol HOLX
Full Company Profile

Analyst Forecast

According to 14 analyst ratings, the average rating for HOLX stock is "Hold." The 12-month stock price forecast is $83, which is an increase of 53.32% from the latest price.

Stock Forecasts

Earnings Surprise

Hologic has released their quartely earnings on May 1, 2025:
  • Revenue of $1.05B exceeds estimates by $55M, with 3.63% YoY growth.
  • EPS of 1.03 exceeds estimates by 0.01, with 0.00% YoY growth.
  • 2 months ago
    -10.1%
    Hologic shares are trading lower after the company... Unlock content with Pro Subscription
    6 months ago
    -5.88%
    Hologic shares are trading lower. The company reported Q4 financial results.